{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T21:03:47Z","timestamp":1767474227713},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2007,8,30]],"date-time":"2007-08-30T00:00:00Z","timestamp":1188432000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ophthalmologe"],"published-print":{"date-parts":[[2007,9]]},"DOI":"10.1007\/s00347-007-1608-8","type":"journal-article","created":{"date-parts":[[2007,8,28]],"date-time":"2007-08-28T11:12:40Z","timestamp":1188299560000},"page":"817-828","source":"Crossref","is-referenced-by-count":29,"title":["Chronische Blepharitis"],"prefix":"10.1007","volume":"104","author":[{"given":"C.","family":"Auw-Haedrich","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Reinhard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,8,30]]},"reference":[{"key":"1608_CR1","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.ophtha.2003.05.035","volume":"111","author":"Akpek","year":"2004","unstructured":"Akpek EK, Dart JK, Watson S et al. (2004) A randomized trial of topical cyclosporin 0.05% in topical steroid-resistant atopic keratoconjunctivitis. Ophthalmology 111: 476\u2013482","journal-title":"Ophthalmology"},{"key":"1608_CR2","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1007\/s00417-003-0699-4","volume":"241","author":"Auw-Haedrich","year":"2003","unstructured":"Auw-Haedrich C, Feltgen N (2003) Oestrogen receptor expression in Meibomian glands and its correlation with age and dry-eye parameter. Graefes Arch Clin Exp Ophthalmol 241: 705\u2013709","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1608_CR3","doi-asserted-by":"crossref","unstructured":"Baudouin C (2001) The pathology of dry eye. Surv Ophthalmol [Suppl 2] 45: S211\u2013220","DOI":"10.1016\/S0039-6257(00)00200-9"},{"key":"1608_CR4","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.ophtha.2004.11.037","volume":"112","author":"Ben","year":"2005","unstructured":"Ben Simon GJ, Huang L, Nakra T et al. (2005) Intralesional triamcinolone acetonide injection for primary and recurrent chalazia: is it really effective? Ophthalmology 112: 913\u2013917","journal-title":"Ophthalmology"},{"key":"1608_CR5","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/eye.1991.65","volume":"5","author":"Bron","year":"1991","unstructured":"Bron AJ, Benjamin L, Snibson GR (1991) Meibomian gland disease. Classification and grading of lid changes. Eye 5: 395\u2013411","journal-title":"Eye"},{"key":"1608_CR6","first-page":"101","volume":"249","author":"De","year":"1993","unstructured":"De Leener H, Maudgal PC (1993) Chronic blepharitis, meibomitis and corneal lesions. Bull Soc Belge Ophtalmol 249: 101\u2013106","journal-title":"Bull Soc Belge Ophtalmol"},{"key":"1608_CR7","first-page":"486","volume":"27","author":"Dougherty","year":"1986","unstructured":"Dougherty JM, McCulley JP (1986) Bacterial lipases and chronic blepharitis. Invest Ophthalmol Vis Sci 27: 486\u2013491","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1608_CR8","first-page":"1932","volume":"32","author":"Dougherty","year":"1991","unstructured":"Dougherty JM, Osgood JK, McCulley JP (1991) The role of wax and sterol ester fatty acids in chronic blepharitis. Invest Ophthalmol Vis Sci 32: 1932\u20131937","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1608_CR9","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0039-6257(96)80064-6","volume":"40","author":"Driver","year":"1996","unstructured":"Driver PJ, Lemp MA (1996) Meibomian gland dysfunction. Surv Ophthalmol 40: 343\u2013367","journal-title":"Surv Ophthalmol"},{"key":"1608_CR10","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1001\/archopht.123.12.1667","volume":"123","author":"Hammersmith","year":"2005","unstructured":"Hammersmith KM, Cohen EJ, Blake TD et al. (2005) Blepharokeratoconjunctivitis in children. Arch Ophthalmol 123: 1667\u20131670","journal-title":"Arch Ophthalmol"},{"key":"1608_CR11","first-page":"6","volume":"92","author":"Heiligenhaus","year":"1995","unstructured":"Heiligenhaus A, Koch JM, Kruse FE et al. (1995) Diagnostik und Differenzierung von Benetzungsst\u00f6rungen. Ophthalmologe 92: 6\u201311","journal-title":"Ophthalmologe"},{"key":"1608_CR12","doi-asserted-by":"crossref","first-page":"R55","DOI":"10.1055\/s-2005-865974","volume":"222","author":"Huber-Spitzy","year":"2005","unstructured":"Huber-Spitzy V (2005) Blepharitis. Klin Monatsbl Augenheilkd 222: R55\u201372","journal-title":"Klin Monatsbl Augenheilkd"},{"key":"1608_CR13","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1007\/s00347-004-1115-0","volume":"101","author":"Kaercher","year":"2004","unstructured":"Kaercher T, Brewitt H (2004) Blepharitis. Ophthalmologe 101: 1135\u20131148","journal-title":"Ophthalmologe"},{"key":"1608_CR14","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1001\/archopht.1992.01080170136042","volume":"110","author":"Kersten","year":"1992","unstructured":"Kersten RC, Kleiner FP, Kulwin DR (1992) Tarsotomy for the treatment of cicatricial entropion with trichiasis. Arch Ophthalmol 110: 714\u2013717","journal-title":"Arch Ophthalmol"},{"key":"1608_CR15","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1084\/jem.172.6.1609","volume":"172","author":"Kock","year":"1990","unstructured":"Kock A, Schwarz T, Kirnbauer R et al. (1990) Human keratinocytes are a source for tumor necrosis factor alpha: evidence for synthesis and release upon stimulation with endotoxin or ultraviolet light. J Exp Med 172: 1609\u20131614","journal-title":"J Exp Med"},{"key":"1608_CR16","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/00003226-199107000-00001","volume":"10","author":"Mathers","year":"1991","unstructured":"Mathers WD, Shields WJ, Sachdev MS et al. (1991) Meibomian gland dysfunction in chronic blepharitis. Cornea 10: 277\u2013285","journal-title":"Cornea"},{"key":"1608_CR17","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1055\/s-2001-18665","volume":"218","author":"Mayer","year":"2001","unstructured":"Mayer K, Reinhard T, Reis A et al. (2001) 0,1% FK 506-Salbe \u2013 Eine neue therapeutische Option bei der atopischen Blepharitis. Klinische Studie an 14 Patienten. Klin Monatsbl Augenheilkd 218: 733\u2013736","journal-title":"Klin Monatsbl Augenheilkd"},{"key":"1608_CR18","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1097\/00003226-200009000-00010","volume":"19","author":"McCulley","year":"2000","unstructured":"McCulley JP, Shine WE (2000) Changing concepts in the diagnosis and management of blepharitis. Cornea 19: 650\u2013658","journal-title":"Cornea"},{"key":"1608_CR19","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0014-4835(03)00203-3","volume":"78","author":"McCulley","year":"2004","unstructured":"McCulley JP, Shine WE (2004) The lipid layer of tears: dependent on meibomian gland function. Exp Eye Res 78: 361\u2013365","journal-title":"Exp Eye Res"},{"key":"1608_CR20","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/S0161-6420(82)34669-2","volume":"89","author":"McCulley","year":"1982","unstructured":"McCulley JP, Dougherty JM, Deneau DG (1982) Classification of chronic blepharitis. Ophthalmology 89: 1173\u20131180","journal-title":"Ophthalmology"},{"key":"1608_CR21","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/01.ico.0000176611.88579.0a","volume":"25","author":"Perry","year":"2006","unstructured":"Perry HD, Doshi-Carnevale S, Donnenfeld ED et al. (2006) Efficacy of commercially available topical cyclosporine A 0.05% in the treatment of meibomian gland dysfunction. Cornea 25: 171\u2013175","journal-title":"Cornea"},{"key":"1608_CR22","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1089\/jop.2006.22.47","volume":"22","author":"Rubin","year":"2006","unstructured":"Rubin M, Rao SN (2006) Efficacy of topical cyclosporin 0.05% in the treatment of posterior blepharitis. J Ocul Pharmacol Ther 22: 47\u201353","journal-title":"J Ocul Pharmacol Ther"},{"key":"1608_CR23","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1001\/archopht.116.7.849","volume":"116","author":"Shine","year":"1998","unstructured":"Shine WE, McCulley JP (1998) Keratoconjunctivitis sicca associated with meibomian secretion polar lipid abnormality. Arch Ophthalmol 116: 849\u2013852","journal-title":"Arch Ophthalmol"},{"key":"1608_CR24","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1076\/ceyr.26.2.89.14515","volume":"26","author":"Shine","year":"2003","unstructured":"Shine WE, McCulley JP (2003) Polar lipids in human meibomian gland secretions. Curr Eye Res 26: 89\u201394","journal-title":"Curr Eye Res"},{"key":"1608_CR25","first-page":"2291","volume":"34","author":"Shine","year":"1993","unstructured":"Shine WE, Silvany R, McCulley JP (1993) Relation of cholesterol-stimulated Staphylococcus aureus growth to chronic blepharitis. Invest Ophthalmol Vis Sci 34: 2291\u20132296","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1608_CR26","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1001\/archopht.120.12.1689","volume":"120","author":"Sullivan","year":"2002","unstructured":"Sullivan BD, Evans JE, Cermak JM et al. (2002) Complete androgen insensitivity syndrome. Effect on human Meibomian gland secretions. Arch Ophthalmol 120: 1689\u20131699","journal-title":"Arch Ophthalmol"},{"key":"1608_CR27","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1001\/archopht.1946.00890210453002","volume":"36","author":"Thygeson","year":"1946","unstructured":"Thygeson P (1946) Etiology and treatment of blepharitis. Arch Ophthalmol 36: 445\u2013477","journal-title":"Arch Ophthalmol"}],"container-title":["Der Ophthalmologe"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-007-1608-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00347-007-1608-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-007-1608-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T13:50:49Z","timestamp":1559051449000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00347-007-1608-8"}},"subtitle":["Pathogenese, klinischer Verlauf und therapeutische Ans\u00e4tze"],"short-title":[],"issued":{"date-parts":[[2007,8,30]]},"references-count":27,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2007,9]]}},"alternative-id":["1608"],"URL":"https:\/\/doi.org\/10.1007\/s00347-007-1608-8","relation":{},"ISSN":["0941-293X","1433-0423"],"issn-type":[{"value":"0941-293X","type":"print"},{"value":"1433-0423","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,8,30]]}}}